Doctor: 'No problems' after Antioch toddler undergoes kidney and liver transplant
Silicon Valley MercuryNews.com - June 05, 2013
"The sun wasn't up at 5 o'clock Wednesday
morning, but a new day had already dawned for Matthew
Ouimet. Matthew, a 2-year-old
Antioch boy who had waited 15 months for a life-sustaining kidney
and liver transplant, had his new organs. Dr. John
Roberts took the lead on the liver transplant, and Dr.
Peter Stock, who handled the kidney procedure in a 12-hour
surgery that began around 6 p.m. Tuesday, delivered the good news
to parents Kristi and Kelly Ouimet and a half-dozen family members
who spent the night at UCSF Benioff Children's
Hospital. "They look pretty good," Stock said of the
transplanted organs. "There were no problems. He's very
stable." Excerpts from story at
Silicon Valley MercuryNews.com
Chair Portrayed in Synapse Article as Exceptional Mentor
UCSF Synapse - June 01, 2013
"Dr. (Nancy)
Ascher excels in her role as Chair of Surgery, not
only for her inexplicable foresight, but because she stays
connected to trainees and students. This year, Dr. Ascher received
the Francis Moore Excellence in Mentorship in the Field of
Transplantation Surgery Award from the American Society of
Transplant Surgeons."
"Residents and fellows noted that Dr. Nancy Ascher is an
effective mentor because she treats them like colleagues and not
just trainees. Residents and fellows felt "immersed and integral in
the program which empowered them and helped their growth." Dr.
Ascher emphasizes that a meaningful mentor-mentee relationship
allows an honest exchange about the student's career path and the
mentor's willingness to be that student's advocate."
"Early Riser" - A Day in the Life of Dr. Nancy Ascher
UCSF Magazine, Spring 2013 - May 30, 2013
"It was 1975 when Nancy Ascher, MD, PhD, chose surgery, a specialty shoulder-deep in men. Then again, so was medical school - Ascher was one of 20 women in her class of 180. After her residency, she blew past every gender barrier to become the first woman to perform a liver transplant, garnering enough speed to break through the stainless-steel ceiling to serve as UCSF's first female chair of surgery - one of three women holding that title in the country. The pace at which Ascher propels through every day is the velocity required for the steep ascent of a remarkable career." Excerpt from UCSF Magazine, Spring 2013
18th Annual Chris Mudge UCSF Pediatric Transplant Picnic
University of California, San Francisco - May 29, 2013
UCSF is pleased to announce its annual Pediatric Transplant Picnic at McNears Beach in San Rafael, CA on Saturday, August 24, 2013, from 10 am - 4 pm, a celebration in honor of children who have been patients in the transplant program and their families. Attendees will be treated to music, dancing, kayaking, face-painting, piñatas, and more. Food and drinks will be provided, but guests are also encouraged to bring potluck dishes corresponding to the first letter of their last name: Veggies (A-G), Snacks (H-P) and fruit (Q-Z). Please, no dogs or alcohol. RSVP toaurora.bermudez@ucsfmedctr.orgor (415) 476-8636 by 8/9
"Innovation in medicine is driven by need, but also by the market,"
said Dr. Michael R. Harrison, the director emeritus of the Fetal
Treatment Center and the director of the Pediatric Device
Consortium, both at the University of California, San Francisco.
"Big markets have lots of folks developing devices, but small
markets like the pediatrics market don't."
Lung Cancer Systems Genetics Expands Map of Drug Discovery
UCSF Thoracic Oncology Program and Laboratory, Kim Lab - April 19, 2013
In the journal Nature Communications, lead
author Il-Jin Kim, Ph.D., (pictured
left) Director of Applied Genomics in the UCSFThoracic Oncology
Lab, Thoracic Oncology Program Leader, David M. Jablons, M.D.,
(pictured right) and others, demonstrate the value of mining vast
gene expression networks to expand the pool of therapeutic targets
in lung cancer. This could lead to the discovery of novel druggable targets specific to
lung adenocarcinoma, sparing normal lung tissue, and to anti-cancer
drugs with minimal side toxicity yet with high tumor killing
efficacy.
Awards Announced for 26th Annual J. Engelbert Dunphy Resident Research Symposium
UCSF Department of Surgery - April 09, 2013
The annual
26th Annual J. Engelbert Dunphy Resident Research Symposium was
held on April 5, 2013. The award for "Best Abstract" went to Robert Bell, MD with
runners-up Jessica Beard, MD,
MPH and Randi Smith, MD
MPH. Xiaoti Xu, MD
received the award for
"Best Quick
Shot". Jack Harbell, MD
and Cristina O'Donohue, MD received Honorable Mention certificates
for their presentations.
16th Annual Maurice Galante Lecture Featuring Malcolm Gladwell (Watch Online)
UCSF Department of Surgery - March 15, 2013
The 16th Annual Maurice Galante Lecture took place on
Febuary 22, 2013 and featured Malcolm Gladwell. The video of the
lecture can be
watched online.
Malcolm
Gladwell has been a staff writer with The New Yorker
magazine since 1996. His 1999 profile of Ron Popeil won a National
Magazine Award, and in 2005 he was named one of Time Magazine's 100
Most Influential People. He is the author of four books, "The
Tipping Point: How Little Things Make a Big Difference," (2000),
"Blink: The Power of Thinking Without Thinking" (2005), and
"Outliers: The Story of Success" (2008) all of which were number
one New York Times bestsellers. His latest book, "What the Dog Saw"
(2009) is a compilation of stories published in The New
Yorker.
From 1987 to 1996, he was a reporter with the Washington Post,
where he covered business, science, and then served as the
newspaper's New York City bureau chief. He graduated from the
University of Toronto, Trinity College, with a degree in history.
He was born in England, grew up in rural Ontario, and now lives in
New York City.
Alden H. Harken, M.D. Receives Lifetime Achievement Award from Society of University Surgeons (SUS)
Alameda Health System, Society of University Surgeons - March 15, 2013
Alden H. Harken, M.D.was recently honored with the 2012
Lifetime Achievement Award from the Society of University Surgeons
(SUS). Dr. Harken is Chief of the UCSF-East Bay Surgery Program,
and Chief of
Surgery and Chair of the Surgery Department at Alameda Health
System's (AHS). Over the course of his career, His
contributions to the field of cardiac electrophysiology include
influential early work around mapping and surgical ablation for
ventricular tachyarrhythmias. Dr. Harken's work in this area helped
our understanding of the pathophysiology of ventricular tachycardia
and shaped today's methods of ablative treatment of ischemic
ventricular tachycardia. According to SUS, "Dr. Harken's energy,
insight, enthusiasm and innovative work have created a legacy that
will influence the treatment of cardiac arrhythmias for many years
to come. He has clearly been a pioneer in the field, and has been a
true role model for his colleagues in the SUS and AAS."
*
*Excerpts above from news release
for Alameda Health System's (AHS)
Maurice Galante, M.D., Legendary Surgeon and Renaissance Man, Dies
UCSF Department of Surgery - March 07, 2013
Dr. Maurice Galante, whose professional career at UCSF spanned
an incredible 44 years (1945-1989), passed away on February 5,
2013. Dr. Galante was born in
Rhodes in 1919 and came to the United States alone to receive his
undergraduate and medical education. He entered his residency
training in general surgery at UCSF in 1945. He subsequently became
a member of the Department of Surgery faculty. As a faculty member
at UCSF, Dr. Galante was celebrated as a master surgeon and for his
varied interests in medical ethics, music and the arts. His
reputation with patients was legendary and his grateful patients
helped him and the Department of Surgery establish the Galante
Lecture Program, The Galante Research Program and the Maurice
Galante Distinguished Professorship.
Rogers Urges Caution on New Medical Device to Treat GERD
U.S. News - February 22, 2013
A recent
study in the New England Journal of Medicine touts a new
medical device for the treatment of
Gastroesophageal Reflux Disease (GERD) as an alternative
to standard therapy, long-term proton-pump inhibitors or
Nissen Fundoplication. The
new treatment is a surgical procedure in which a small band of
magnetic beads is surgically implanted to augment the lower esophageal
sphincter, the valve
between the esophagus and stomach.
ButStanley J. Rogers, M.D.,Associate Professor of Surgery at
UCSF,Chief of Minimally
Invasive Surgery, and Chief of Bariatric Surgery, expressed concern
about its use, telling CBS/KCBS News Healthwatch that the
device was essentially
untested except for the small study cited above. He cautioned that
the beads were a foreign
object and where the device was placed could
potentially cause serious complications including infection,
perforation and abdominal sepsis, leading to ultimate removal. He
emphasized that long-term data was needed to demonstrate
its safety and effectiveness.
Ventricular Assist Device (VAD) Serves as Bridge to Heart Transplant While Candidate Loses Required Weight
UCSF Department of Surgery, UCSF New - February 01, 2013
Suitulaga "Sugi" Hunkin has been overweight most of his
life. He attributes that to his love of food and his Samoan
ancestry. Because of
his size, he also had trouble breathing and experienced irregular
heartbeat - symptoms his doctors diagnosed as heart disease called
cardiomyopathy, which usually leads to heart
failure...........He needed
heart transplantation surgery to replace his failing heart, but
before that could happen, he needed to lose at least 100
pounds. "If a patient
is very obese, he bears a lot of risks and complications,
inter-operatively as well as post-operatively," said Georg Wieselthaler.
M.D.,
Professor of Surgery of UC
San Francisco's Division of Adult Cardiothoracic Surgery, and
director and surgical chief of the UCSF Cardiac Transplantation and
Mechanical Circulatory Support. "And therefore it's absolutely
favorable for patients to try and have a body mass index of below
35 before going into a complex operation."
Hunkin chose UCSF to help him with his heart failure. Its
pioneering Cardiothoracic Surgery program, now led by Scot H. Merrick,
M.D., was established 50 years ago by
chair Leon Goldman, MD, and Benson Roe, M.D. The
Heart and Lung Transplant Program has historically had high
one-year survival outcomes among academic surgery programs
nationally. To help Hunkin stay
alive, Wieselthaler installed a ventricular assist device (VAD), a
mechanical device that helps a failing heart pump blood. The VAD
allowed Hunkin stay alive, but it did not help him lose weight.
*Excerpt above adapted from UCSF
News
Il-Jin Kim Awarded Grant to Investigate Novel Genetic Profiles in Mesothelioma
UCSF Thoracic Oncology Program - January 24, 2013
The Mesothelioma Applied Research
Foundation (MARF), a leading national funder of research for this
disease, has awarded Il-Jin Kim, Ph.D., Assistant Professor and Director of
Applied Genomics in the Thoracic Oncology
Laboratory, a grant to study Novel fusion and
tumor-specific isoform candidates in malignant pleural
mesothelioma (MPM), an aggressive and highly lethal cancer, with
the ultimate goal of identifying therapeutic targets. The research
focuses on a class of patient who lack the three most common
genetic deletions (CDKN2A, NF2, and BAP1). Studying the unique
genetic profile of this so-called triple-negative (TN) MPM patient
population may reveal unique genetic characteristics and oncogenic
fusions contributing to MPM development. The goal would be to
target the aberrant cancer-inducting activity in this small group
of patients with novel therapies. This is a similar approach to the
identification of the EML4-ALK fusion genes in non-small cell
lung cancer patients, leading to the novel therapy crizotinib,
an example of 21st century precision medicine.
Teen Liver Transplant Recipient to Honor Donor at 2013 Rose Parade
UCSF News - December 28, 2012
Three years
ago, Alfonso Garcia was diagnosed with Wilson's disease and was in
desperate need of a liver transplant. George Becker, who signed up
to be an organ donor on his driver's license when he was 16, ended
up being the right match. Garcia's UCSF medical team - which
included transplant surgeon Ryutaro Hirose, MD (pictured
first); Philip Rosenthal, MD (pictured
second), medical director of the Pediatric Liver Transplant
Program;
Emily Perito, MD, a clinical fellow in pediatrics and
gastroenterology; and nurse practitioner Susan Diaz, MSN -
performed a successful transplant.Since receiving the liver
transplant, Garcia has made it a mission to spread the word about
the value of organ donation by sharing the memory of his hero,
George Becker, who died after a bad sinus infection spread to his
brain. As part of that mission, Garcia was selected by UCSF and the
California Transplant Donor Network to ride on the Donate Life
"Journeys of the Heart" float at the 2013 Tournament of Roses
Parade in Pasadena, Calif., on Tuesday, Jan. 1., in honor of
Becker. The float will bear a florograph of Becker - a portrait
made of flowers.
UCSF Vascular Surgeon advocates discussing medical challenges associated with space tourism
San Francisco Chronicle, Time Magazine Online, NPR.org - December 14, 2012
The world may be on the brink of a vast new frontier of tourism
- and that could raise a few odd, and at this point unanswerable,
questions for doctors. Space tourism is on the cusp of
becoming a real possibility for people who don't have the health
and fitness of a NASA astronaut, and aerospace medicine experts
including Dr.
Marlene Grenon, M.D., C.M., of the UCSF Division of
Vascular and Endovascular Surgery, believe that now is the time to
think about medical guidelines. There's a wealth of information
about the effects of space travel on government astronauts - from
the symptoms of space sickness to the long-term repercussions of
lengthy stays at the International Space Station. But the effects
on the average person with imperfect health are unknown. In a
paper published in the British Medical Journal, Dr. Grenon and
colleagues provide background in the field of space medicine for
non-experts and clinicians.